Boyanov & Co has advised Bulgarian pharma company Sopharma on its acquisition of a pharmaceutical product portfolio consisting of both CHC and prescription products.
According to Boyanov & Co, "the acquisition covers 68 marketing authorizations with 14 well-known brands in 10 of the traditional markets of Sopharma. The transaction will take effect in several stages, and its closing is subject to certain conditions precedent."
In 2017, Boyanov & Co advised on Pharmastore's acquisition by Sopharma Trading (as reported by CEE Legal Matters on March 24, 2017).
The Boyanov & Co team included Partners Yordan Naydenov, Peter Petrov, and Borislav Notovsky.
Boyanov & Co did not respond to our inquiry on the matter.
